Marie Marchand

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants et al. · International Journal of Cancer · 1999 · 786 citations

Subcutaneous Injections, Immunology, Immunoediting +20

Expression of <i>MAGE</i> genes in primary and metastatic cutaneous melanoma

Francis Brasseur, Donata Rimoldi, Danielle Líénard et al. · International Journal of Cancer · 1995 · 285 citations

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

Frédéric Lehmann, Marie Marchand, P Pouillart et al. · European Journal of Immunology · 1995 · 224 citations

Histocompatibility, T-regulatory Cell, Immunology +18

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene<i>MAGE-3</i>

Pierre G. Coulie, Vaios Karanikas, Didier Colau et al. · Proceedings of the National Academy of Sciences · 2001 · 220 citations · Full text

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Nicolas van Baren, Marie-Claude Bonnet, Brigitte Dréno et al. · Journal of Clinical Oncology · 2005 · 169 citations